Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

methotrexate

methotrexate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Methotrexate SOLUTION, INJECTABLE 25 mg/mL      
Xatmep SOLUTION, ORAL 2.5 mg/mL      
Rheumatrex Dose Pack, Trexall TABLET, ORAL 2.5 mg      
VIEW MORE Antineoplastic Agents
CLASS
100000
High Alert Drug : Policy
Comments:

ISMP oral methotrexate patient education leaflet

Methotrexate is a HIGH-RISK/HIGH-ALERT drug when used orally for non-oncology patients. Use extra caution when methrotrexate prescribed in non-oncology situations.

 

Xatmep is restricted to patients that are unable to take the oral tablet formulation.

 

High dose methotrexate process for Oncology pharmacists: Oncology pharmacist MTX process

High dose methotrexate process for evening/night shift pharmacists: SBAR for evening and night shift pharmacists

 

Reviewed: 24 Oct 2017 (Xatmep)

Updated: March 2023 (Xatmep)

HAZ-MED Liquid Preparations

Last updated: Apr. 11, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved